Resmed (RMD) Income from Non-Controlling Interests (2021)
Resmed (RMD) posted Income from Non-Controlling Interests of $48.1 million for Q3 2021, down 9.76% on a QoQ basis from $53.3 million in Q1 2021.
Resmed (RMD) Income from Non-Controlling Interests (2021) Analysis & Trends
Resmed's Income from Non-Controlling Interests history runs 1 years deep, the most recent figure standing at $48.1 million for Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 33,163,703.85 Bn | 33,163,702.19 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 119.67 Bn | 114.45 Bn | 1.96 Bn | -18.70 Mn |
| 3 | Becton Dickinson | 43.92 Bn | 43.11 Bn | 2.15 Bn | - |
| 4 | Medline | 31.71 Bn | 29.47 Bn | 1.84 Bn | 110.00 Mn |
| 5 | Resmed | 28.46 Bn | 26.80 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 23.80 Bn | 23.28 Bn | 296.40 Mn | - |
| 7 | Cooper Companies | 13.77 Bn | 13.63 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.63 Bn | 13.06 Bn | 1.10 Bn | - |
| 9 | Align Technology | 11.94 Bn | 10.88 Bn | 736.59 Mn | - |
| 10 | Baxter International | 11.56 Bn | 9.54 Bn | 891.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 48.10 Mn |
| Mar 31, 2021 | 53.30 Mn |